Avenue Therapeutics Inc. sell dimontalban
Start price
06.10.22
/
40%
€6.75
Target price
06.10.23
€0.000
Performance (%)
-61.11%
End price
24.10.22
€2.63
Summary
This prediction ended on 24.10.22 with a price of €2.63. The SELL prediction by dimontalban for Avenue Therapeutics Inc. performed very well with a performance of -61.11%. dimontalban has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Avenue Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.922% | -1.993% | 13.399% |
| iShares Nasdaq 100 | 0.371% | -0.868% | 41.541% |
| iShares Nikkei 225® | 2.224% | -5.187% | 20.497% |
| iShares S&P 500 | -0.026% | -0.918% | 30.410% |
According to dimontalban what are the pros and cons of Avenue Therapeutics Inc. for the foreseeable future?
Pros
Capable Management
Good culture
Innovative
Sustainability is important
Cons
Probably not worthwhile Investment
Revenue decline > 20% expected
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Very low/no dividend yield expected
very negative Cash Flow expected
Junk rating
Very little Investments for future growth
High risks in the balance sheet
ROE lower than 5% per year
High challenges to pay loans and raise capital
Few uniques
Dependend from few customers or products
Growths much slower than the competition
high free float
High risks for its business
Below average Marketposition
Very high cyclical dependencies
Unknown brand
Outdated or very high risk business model
Comments by dimontalban for this prediction
In the thread Avenue Therapeutics diskutieren
Sell mit Kursziel 0,0